RecruitingNCT06516458

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

Development of Camera Based Gait Deviation Index for Persons With Multiple Sclerosis


Sponsor

Shirley Ryan AbilityLab

Enrollment

40 participants

Start Date

Jul 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is developing a simple camera-based system that can measure walking quality in people with multiple sclerosis (MS). Using a regular video camera, the system analyzes how a person walks to detect gait problems that might indicate disease progression — potentially providing a cost-effective monitoring tool outside of specialist clinics. **You may be eligible if...** - You have a relapsing form of MS (including relapsing-remitting MS or secondary progressive MS) - You can walk independently - You have not had a relapse (flare-up) in the past month - You are 18–75 years old - If you take dalfampridine (a walking aid medication), your dose has been stable for at least 2 months **You may NOT be eligible if...** - You have had an orthopedic injury, fracture, or surgery that affects your ability to walk or bear weight normally Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCamera Based Kinematic Analysis

Observational Study using Camera Based, Marker Less Kinematic Analysis of gait quality of persons with Multiple Sclerosis


Locations(1)

Shirley Ryan AbilityLab

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06516458


Related Trials